glp 1 agonist drug Can one do it all? Reviewing the expanding clinical universe of GLP-1 agonists GLP-1 Receptor Agonist Market Size
Description
Outcomes The primary outcome was incident major osteoporotic fracture (MOF)
In vitro and preclinical in vivo experiments in arthritis have uncovered weight-loss-independent anti-inflammatory and chondroprotective properties of GLP-1RAs
Haschka, J
A few use it to describe any strategy that restarts stalled weight loss
By 48 weeks, more than 90% had resolved their steatosis entirely
It is a narrative rather than a systematic review
